== Skin biopsy demonstrating perivascular mononuclear infiltrate (arrow) in the superficial dermis as well as vacuolar interface modify, including scattered apoptotic keratinocytes (Grade 2 Graft Versus Host Disease). == Physique 3. Sepsis was the most common cause of death (60%). Enterobacter bacteremia, invasive aspergillosis and disseminated Candida infections were frequently reported. Recipient age group over 50-years is a risk factor intended for GVHD after LT. Hepatocellular carcinoma (HCC) was over-represented, while chronic hepatitis C was under-represented, in reported United States Ibiglustat GVHD cases relative to all UNOS database LT cases. Mortality rate with treatment of GVHD after LT was 84% with high-dose steroids only, 75100% with regimens using dose raises of calcineurin inhibitors (CNI), and 55% with IL-2 antagonists. Mortality was 25% in small case series using the CD2-blocker alefacept or tumor necrosis factor- (TNF-) antagonists. == Conclusions == Age over 50-years and HCC appear to be risk Mouse monoclonal to CD45/CD14 (FITC/PE) factors for GVHD. Hepatitis C may be protective. High-dose steroids and CNI are inadequate in the treatment of GVHD after LT. CD2-blockers and TNF- antagonists appear promising. We propose a diagnostic protocol to assist clinicians in managing adults with GVHD after LT. == INTRODUCTION == Graft-versus-host-disease (GVHD) is an infrequent problem after liver transplantation (LT), with an incidence of 0. 52%13. GVHD occurs as a result of donor immunocompetent cells recognizing recipient antigens because foreign and mounting an immune response. Grafts that contains more immunocompetent donor lymphocytes, such as hematopoietic stem cell, bone marrow or peripheral blood stem cell transplantations, are associated with a high incidence of GVHD. Among solid organ transplants, intestinal transplantation has the greatest incidence of GVHD, followed by LT; with lower rates of GVHD after kidney, heart or pancreas transplantation. The mortality rate intended for GVHD after LT continues to be reported to be up to 85%. 1In this article, we report a case series and a comprehensive review of the literature on GVHD after LT. The epidemiology, risk factors, clinical features, and treatment results are explained; and a diagnostic protocol is proposed. == MATERIALS and METHODS == == University of Iowa Hospitals and Clinics Case Series == Medical records of all patients diagnosed with GVHD after LT at the University of Iowa Hospitals and Clinics (UIHC) were reviewed. GVHD cases were identified from a prospectively maintained list of complications after LT. Diagnosis of GVHD was established with skin and gastrointestinal biopsies. Histologic grading of skin and gastrointestinal GVHD was also performed (seesupplement). 4, 5 GVHD was documented histologically in all patients. Donor chimerism, using a quantitative assay of short tandem DNA repeats (STR) in the cells from the skin, gastrointestinal mucosa, peripheral blood and/or bone marrow, was recorded when available. This study was approved by the University of Iowa Institutional Review Board. == Review of literature on GVHD after LT == A comprehensive search of the databases of biomedical literature (Medline Ibiglustat and Embase) was performed from 1988 (first case report of GVHD after LT) to Ibiglustat 2014. The search strategy is explained inAppendix 1 . All case reports and case series of GVHD after LT in adults were reviewed. Reference lists of published reports were searched to find additional reports. Data on patient demographics, clinical findings, management and results were extracted. Data was extracted from the United Network for Organ Sharing database, until January 2015, intended for group comparisons between reported United States cases of GVHD after LT and all US LT patients. == Statistical Analysis == Observations are reported because frequencies, and central tendencies are expressed as Ibiglustat mean or median with standard deviation and interquartile range, based on the distribution of data. Categorical variables are reported as number and percent frequency of occurrence. Categorical data were compared using Pearsons chi-square or Fishers exact test, where Ibiglustat appropriate. All statistical testing was 2-sided and assessed intended for significance at the 5% level using SAS v9. 4 (SAS Institute, Cary, NC). == RESULTS == == UIHC Case Series == A total of 762 LT were performed in adults from 1988 to January 31st2015. Five recipients (0. 7%) developed GVHD. A summary of the case series at.